Nonopioids: NSAIDs, Selective Cyclooxygenase-2 Inhibitors, and Acetaminophen - pediagenosis
Article Update
Loading...

Wednesday, June 16, 2021

Nonopioids: NSAIDs, Selective Cyclooxygenase-2 Inhibitors, and Acetaminophen

Nonopioids: NSAIDs, Selective Cyclooxygenase-2 Inhibitors, and Acetaminophen


Nonopioids: NSAIDs, Selective Cyclooxygenase-2 Inhibitors, and Acetaminophen

Nonsteroidal antiinflammatory drugs have good analgesic efficacy (but often less than that of opioids), relatively rapid onset, and adverse effects (eg, possibly fatal gastrointestinal bleeding and disturbed salt and water balance). All NSAID effects—analgesic, antiinflammatory, antipyretic, and antiplatelet—are thought to be due to decreased prostanoid biosynthesis via COX inhibition. Traditional NSAIDs inhibit both COX­1 and ­2 isoforms, but newer COX­2 inhibitors are more selective. The analgesic efficacy of selective COX­2 inhibitors (coxibs) is approximately equal to that of traditional NSAIDs, but the adverse effects of COX­2 inhibition have yet to be fully characterized and are somewhat controversial. The ability to selectively inhibit COX­2 has been related to the difference in amino acids at position 523 of COX­1 and COX­2: isoleucine in COX­1, valine in COX­2. The mechanism of action of acetaminophen is uncertain but is thought to be via CNS effects.


Share with your friends

Give us your opinion

Note: Only a member of this blog may post a comment.

Notification
This is just an example, you can fill it later with your own note.
Done